Donald Strickland
Directeur Technique/Scientifique/R&D chez VIRACTA THERAPEUTICS, INC.
Provenance du réseau au premier degré de Donald Strickland
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 18 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Donald Strickland via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CVS HEALTH CORPORATION | Drugstore Chains | Corporate Officer/Principal | |
| XOMA CORPORATION | Pharmaceuticals: Major | Investor Relations Contact | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
American Medical Association
 American Medical Association Miscellaneous Commercial ServicesCommercial Services American Medical Association engages in promoting the art and science of medicine and the betterment of public health. It offers services to physicians, residents, medical students, and patients. The company was founded by Nathan Smith Davis in 1847 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Medco Health Solutions, Inc.
 Medco Health Solutions, Inc. Medical/Nursing ServicesHealth Services Medco Health Solutions, Inc. retails drugs, pharmaceuticals and other health products through online. The firm provides pharmacy services which are designed for private and public employers, health plans, labor unions government agencies of all sizes and individuals. The company was founded in June 1983 and is headquartered in Franklin Lakes, NJ. | Medical/Nursing Services | Corporate Officer/Principal | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | President | |
| ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree | |
| Vanderbilt University | College/University | Undergraduate Degree | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
DLA Piper LLP (United States)
 DLA Piper LLP (United States) Miscellaneous Commercial ServicesCommercial Services DLA Piper LLP provides legal services to clients. It offers services in the areas of corporate and securities, venture capital and emerging companies, litigation. The company was founded in 2005 and it is headquartered in Baltimore, MD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| The University of Alabama | College/University | Masters Business Admin | |
| St. John's University | College/University | Undergraduate Degree | |
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | President | |
| University of California San Diego | College/University | Corporate Officer/Principal Masters Business Admin | |
| University of Belgrade | College/University | Graduate Degree | |
| CONTRAFECT CORPORATION | Biotechnology | Chief Executive Officer Director/Board Member | |
| Weill Cornell Medical College | College/University | Doctorate Degree | |
| Università degli Studi di Modena e Reggio Emilia | College/University | Doctorate Degree | |
| Tibotec Pharmaceuticals | Chief Executive Officer | ||
| CANTARGIA AB | Pharmaceuticals: Major | Director/Board Member | |
| USC Marshall School of Business | College/University | Masters Business Admin | |
| COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Chairman | |
Suneva Medical, Inc.
 Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Suneva Medical, Inc. develops, manufactures and commercializes novel, differentiated aesthetic products for the dermatology, plastic, and cosmetic surgery markets. It offers ArteFill, ReFissa, Bellafill, and ReGenica Skincare products. The company is headquartered in San Diego, CA. | Electronic Equipment/Instruments | General Counsel | |
| SERA PROGNOSTICS, INC. | Medical/Nursing Services | Director/Board Member | |
| THERAPEUTICSMD, INC. | Pharmaceuticals: Major | Director/Board Member | |
Real Endpoints LLC
 Real Endpoints LLC Data Processing ServicesTechnology Services Real Endpoints LLC provides information and analytics services. It offers information platform to reveal insights about the changing world of product reimbursement. The firm operates its business through Reimbursement Intelligence and RxScorecard. The company was founded by Roger Longman in 2010 and is headquartered in Westport, CT. | Data Processing Services | Corporate Officer/Principal | |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Chief Executive Officer | |
| University of Virginia School of Law | College/University | Graduate Degree | |
SilverScript Insurance Co.
 SilverScript Insurance Co. Life/Health InsuranceFinance SilverScript Insurance Co. provides health insurance services. It offers Medicare Part D plans for those eligible to enroll in a Medicare prescription drug plan. The company is headquartered in Phoenix, AZ. | Life/Health Insurance | Director/Board Member | |
| REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director/Board Member | |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Biotechnology | Chairman | |
| EVOFEM BIOSCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Chief Executive Officer Director/Board Member Chairman Director/Board Member | |
| Jane Barlow & Associates LLC | Chief Executive Officer | ||
| OMEGA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Pharmaceuticals: Major | Director/Board Member | |
Point Health Tech, Inc.
 Point Health Tech, Inc. Packaged SoftwareTechnology Services Point Health Tech, Inc. engages in the development of healthcare navigation platform and marketplace. The company is headquartered in Austin, TX. | Packaged Software | Director/Board Member | |
| The Creighton University School of Medicine | College/University | Doctorate Degree | |
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Verimmune, Inc.
 Verimmune, Inc. BiotechnologyHealth Technology Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 38 |
| Israël | 3 |
| Royaume-Uni | 2 |
| Suisse | 2 |
| Canada | 2 |
Sectorielle
| Health Technology | 25 |
| Consumer Services | 13 |
| Commercial Services | 4 |
| Health Services | 3 |
| Finance | 3 |
Opérationnelle
| Director/Board Member | 73 |
| Corporate Officer/Principal | 49 |
| President | 22 |
| Independent Dir/Board Member | 22 |
| Chief Executive Officer | 19 |
Relations les plus connectées
| Insiders | |
|---|---|
| Ivor Royston | 30 |
| Roger Pomerantz | 30 |
| Jane Barlow | 15 |
| Barry Simon | 15 |
| Mark Rothera | 14 |
| Thomas Darcy | 13 |
| Stephen Rubino | 10 |
| Flavia Borellini | 9 |
| Sam Murphy | 8 |
| Jane Chung | 7 |
| Darrel Cohen | 7 |
| Stewart M. Brown | 6 |
| Cheryl A. Madsen | 5 |
| Ayman El-Guindy | 4 |
| Patric Nelson | 4 |
- Bourse
- Insiders
- Donald Strickland
- Connexions Sociétés
